Close Close
Sign In
Newsletters
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
Podcast Center Video Center Webcasts Resource Center Events
About ThinkAdvisor Contact Us Advertise With Us Asset & Logo Licensing Sitemap Terms of Service Privacy Policy Copyright © 2024 ALM Global, LLC. All Rights Reserved.
ThinkAdvisor

Portfolio > Alternative Investments > Hedge Funds

Former Morgan Stanley Hedge Fund, FrontPoint, to Close Funds

By Kate McBride

X
Your article was successfully shared with the contacts you provided.

FrontPoint Partners, the beleaguered hedge fund operation that completed a spinoff from Morgan Stanley in March, will reportedly “be winding down select strategies,” according to a report in The News York Times' Dealbook blog on Friday.

Redemptions are the cause, according to the Dealbook report. The fund’s assets had declined to an estimated  $3.1 billion at the end of March from $7.5 billion as of last November, according to an article in Pension & Investments on March 1 announcing the completion of the spinoff.

A FrontPoint Partners portfolio manager, Dr. Joseph "Chip" Skowron, was accused by the SEC of “insider trading.”

Skowron was also criminally charged with securities fraud as well as conspiracy to commit securities fraud and conspiracy to obstruct justice by the Manhattan U.S. Attorney on April 13, and surrendered to the FBI according to a Bloomberg report.

In another insider trading case, Preet Bharara, the U.S. attorney for Manhattan, recently won a conviction against Raj Rajaratnam, the billionaire founder of the hedge fund Galleon Group.

FrontPoint Partners was bought by Morgan Stanley in 2006 when the fund had $5.5 billion in assets under management.

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.